Apr 8, 2025· Comment from Association for Accessible Medicines (AAM)· FDA-2024-D-4689-0079
Comments from the Association for Accessible Medicines (AAM): Considerations for the Use of Artificial Intelligence to Support Regulatory Decision- Making for Drug and Biological Products